• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

    1/20/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    • Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%, all YoY
      • Adjusted sales of $6.0 billion with organic growth of 2.2% YoY
      • Adjusted operating margin of 21.1%, up 140 bps YoY
      • Adjusted EPS of $1.83, up 9% YoY
    • Q4 operating cash flow of $1.6 billion with adjusted free cash flow of $1.3 billion
    • Full-year GAAP sales of $24.9 billion, up 1.5%; operating margin of 18.6%, down 100 bps; EPS of $6.00, down 17%, all YoY
      • Adjusted sales of $24.3 billion with organic growth of 2.1% YoY
      • Adjusted operating margin of 23.4%, up 200 bps YoY
      • Adjusted EPS of $8.06, up 10% YoY
    • Full-year operating cash flow of $2.3 billion with adjusted free cash flow of $4.4 billion

    ST. PAUL, Minn., Jan. 20, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported fourth-quarter and full-year 2025 results.

    "2025 was an important year for 3M as we build a strong foundation that is reshaping our operating model and driving sustainable value creation," said William Brown, 3M Chairman and CEO. "I want to thank the team for their dedication to eXcellence, which helped us finish 2025 with growth above macro, strong margin expansion, double-digit earnings growth, and solid cash conversion. Our accelerated pace of innovation and commercial execution positions us to outperform the macro environment again in 2026. Our continued operating rigor supports further margin expansion and earnings growth, putting us on a clear path to meet or exceed the 2027 financial commitments we outlined at our Investor Day last year."

    Fourth-quarter highlights:









    Q4 2025



    Q4 2024







    GAAP EPS from continuing operations (GAAP EPS)



    $          1.07



    $          1.33







    Special items:















      Net costs for significant litigation



    0.56



    (0.07)







      (Increase) decrease in value of Solventum ownership



    (0.30)



    0.24







      Pension risk transfer charge



    —



    0.02







      Manufactured PFAS products



    0.39



    0.16







      Transformation costs



    0.11



    —







    Adjusted EPS from continuing operations (adjusted EPS)



    $          1.83



    $          1.68























    Memo:















    GAAP operating income margin



    13.0 %



    18.1 %







    Adjusted operating income margin



    21.1 %



    19.7 %



    • GAAP EPS of $1.07 and operating margin of 13.0%.
    • Adjusted EPS of $1.83, up 9% year-on-year.
    • Adjusted operating income margin of 21.1%, an increase of 140 basis points year-on-year.








    GAAP



    Adjusted (non-GAAP)







    Net sales (billions)



    $6.1



    $6.0







    Sales change















    Total sales



    2.1 %



    3.7 %







    Components of sales change:















     Organic sales



    0.6



    2.2







     Acquisitions/divestitures



    (0.1)



    (0.1)







     Translation



    1.6



    1.6







    Adjusted sales excludes manufactured PFAS products.



    • Sales of $6.1 billion, up 2.1% year-on-year with organic sales up 0.6% year-on-year.
    • Adjusted sales of $6.0 billion, up 3.7% year-on-year with adjusted organic sales up 2.2% year-on-year.
    • 3M returned $0.9 billion to shareholders via dividends and share repurchases.
    • Cash from operations of $1.6 billion.
    • Adjusted free cash flow of $1.3 billion.

    Full-Year highlights:









    Full-Year 2025



    Full-Year 2024







    GAAP EPS



    $          6.00



    $          7.26







    Special items:















    Net costs for significant litigation



    1.95



    1.32







    (Increase) decrease in value of Solventum ownership



    (0.78)



    (2.83)







    Pension risk transfer charge



    —



    1.11







    Manufactured PFAS products



    0.47



    0.20







    Loss on business divestitures



    0.29



    —







    Divestiture costs



    —



    0.24







    Transformation costs



    0.13



    —







    Adjusted EPS



    $          8.06



    $          7.30























    Memo:















    GAAP operating income margin



    18.6 %



    19.6 %







    Adjusted operating income margin



    23.4 %



    21.4 %



    • GAAP EPS of $6.00 and operating margin of 18.6%.
    • Adjusted EPS of $8.06, up 10% year-on-year.
    • Adjusted operating income margin of 23.4%, an increase of 200 basis points year-on-year.








    GAAP



    Adjusted (Non-GAAP)







    Net sales (billions)



    $24.9



    $24.3







    Sales change















    Total sales



    1.5 %



    2.7 %







    Components of sales change:















     Organic sales



    0.9



    2.1







     Acquisitions/divestitures



    0.2



    0.2







     Translation



    0.4



    0.4







    Adjusted sales excludes manufactured PFAS products.



    • Sales of $24.9 billion, up 1.5% year-on-year with organic sales up 0.9% year-on-year.
    • Adjusted sales of $24.3 billion, up 2.7% year-on-year with adjusted organic sales up 2.1% year-on-year.
    • 3M returned $4.8 billion to shareholders via dividends and share repurchases.
    • Cash from operations of $2.3 billion.
    • Adjusted free cash flow of $4.4 billion.

    This document includes reference to certain non-GAAP measures. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.

    Full-year 2026 guidance

    3M provided the following full-year 2026 expectations.

    • Adjusted total sales growth1 of ~4 percent, reflecting adjusted organic sales growth1 of ~3 percent.
    • Adjusted operating income margin expansion1 of 70 bps to 80 bps.
    • Adjusted EPS1 in the range of $8.50 to $8.70.
    • Adjusted operating cash flow1 of $5.6 to $5.8 billion, contributing to >100 percent adjusted free cash flow conversion1.

    1As further discussed at 4 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

    Conference call

    3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

    • Live webcast at https://investors.3M.com
    • Webcast replay at https://investors.3m.com/financials/quarterly-earnings

    Consolidated financial statements and supplemental financial information non-GAAP measures

    View the Financial Statement Information on 3M's website: https://investors.3m.com/financials/quarterly-earnings

    Forward-looking statements

     This document contains forward-looking statements. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast," "future," "outlook," "guidance" and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; trade restrictions such as sanctions, tariffs, reciprocal and retaliatory tariffs, and other tariff-related measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals, known as "PFAS," including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's exit of PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement ("PWS Settlement") to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to ongoing PFAS-related settlements and claims; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K (Reports), as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs ("CAE") and related products. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

    About 3M

    3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M.com/news.

    Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's News Center and the social media channels such as @3M or @3MNews.

    Contacts

    3M

    Investor Contact:

    Diane Farrow, 612-202-2449

    Media Contact:

    3MNews@mmm.com

     

    3M (PRNewsfoto/3M)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-reports-fourth-quarter-and-full-year-2025-results-initiates-full-year-2026-financial-guidance-302664991.html

    SOURCE 3M Company

    Get the next $MMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    7/17/2026$180.00Neutral → Overweight
    Analyst
    6/15/2026$190.00Buy
    Goldman
    6/10/2026$131.00Underperform
    Bernstein
    1/16/2026$182.00Overweight → Neutral
    Analyst
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    More analyst ratings

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    3M upgraded by Analyst with a new price target

    Analyst upgraded 3M from Neutral to Overweight and set a new price target of $180.00

    7/17/26 8:16:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Goldman resumed coverage on 3M with a new price target

    Goldman resumed coverage of 3M with a rating of Buy and set a new price target of $190.00

    6/15/26 8:11:43 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Bernstein initiated coverage on 3M with a new price target

    Bernstein initiated coverage of 3M with a rating of Underperform and set a new price target of $131.00

    6/10/26 8:40:45 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    SEC Filings

    View All

    SEC Form 144 filed by 3M Company

    144 - 3M CO (0000066740) (Subject)

    7/22/26 1:41:07 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by 3M Company

    10-Q - 3M CO (0000066740) (Filer)

    7/21/26 12:08:01 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    7/21/26 6:34:07 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance

    Q2 GAAP sales of $6.5 billion, up 2.4%; operating margin of 15.1%, down 290 bps; EPS of $1.78, up 33%, all YoY Adjusted sales of $6.5 billion with organic growth of 5.4% YoYAdjusted operating margin of 24.9%, up 40 bps YoYAdjusted EPS of $2.40, up 11% YoYQ2 operating cash flow of $1.0 billion with adjusted free cash flow of $1.3 billion2026 adjusted EPS guidance increased from $8.50 - $8.70 to $8.80 - $8.95ST. PAUL, Minn., July 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported second-quarter results."We delivered a strong second quarter, exceeding expectations with mid-single-digit sales growth, robust operating margins of about 25%, and double-digit EPS growth, reflecting the progress w

    7/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M and Microsoft announce strategic partnership to advance AI data center infrastructure and enterprise transformation

    Microsoft becomes first announced hyperscale cloud provider to deploy 3M Expanded Beam Optical (EBO) technology 3M to use Microsoft AI and digital capabilities to advance enterprise transformation across key functions ST. PAUL, Minn. and REDMOND, Wash., July 15, 2026 /PRNewswire/ -- 3M (NYSE:MMM) and Microsoft (NASDAQ:MSFT) today announced a strategic partnership focused on AI data center infrastructure and enterprise transformation. Microsoft's Azure Cloud and AI Infrastructure will become the first announced hyperscale cloud provider to deploy 3M's Expanded Beam Optical (EBO) technology. 3M will also use Microsoft's AI and digital platforms as part of its enterprise transformation across k

    7/15/26 9:01:00 AM ET
    $MMM
    $MSFT
    Medical/Dental Instruments
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Scotch™ Brand launches Scotch Kids® Tape for young creators

    New kid-friendly collection supports hands-on creativity, crafting and building for children ages four and upST. PAUL, Minn., July 14, 2026 /PRNewswire/ -- Scotch™ Brand has launched Scotch® Kids Tape to help children create, craft and share their creativity. Designed for kids ages four and up, Scotch® Kids Tape supports crafting, decorating and building projects for young creators. The new line encourages children to confidently apply their imagination and bring their biggest ideas to life with simple materials and without the mess of glue."Kids are natural creators, builders and problem-solvers," said Amanda Dauphiniais, vice

    7/14/26 7:46:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group President Bauer Wendy A exercised 7,952 shares at a strike of $159.96 and covered exercise/tax liability with 3,558 shares, increasing direct ownership by 94% to 9,086 units (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    7/2/26 9:13:09 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Director Rumsey Jennifer was granted 1,196 shares (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    6/9/26 4:07:08 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Rumsey Jennifer

    3 - 3M CO (0000066740) (Issuer)

    6/9/26 4:04:16 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Financials

    Live finance-specific insights

    View All

    3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance

    Q2 GAAP sales of $6.5 billion, up 2.4%; operating margin of 15.1%, down 290 bps; EPS of $1.78, up 33%, all YoY Adjusted sales of $6.5 billion with organic growth of 5.4% YoYAdjusted operating margin of 24.9%, up 40 bps YoYAdjusted EPS of $2.40, up 11% YoYQ2 operating cash flow of $1.0 billion with adjusted free cash flow of $1.3 billion2026 adjusted EPS guidance increased from $8.50 - $8.70 to $8.80 - $8.95ST. PAUL, Minn., July 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported second-quarter results."We delivered a strong second quarter, exceeding expectations with mid-single-digit sales growth, robust operating margins of about 25%, and double-digit EPS growth, reflecting the progress w

    7/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., July 7, 2026 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event:Second-quarter 2026 earnings conference call on Tuesday, July 21, 2026, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M

    7/7/26 10:15:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., May 12, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the second quarter of 2026. The dividend is payable June 12, 2026, to shareholders of record at the close of business on May 22, 2026.3M has paid dividends to its shareholders without interruption for more than 100 years.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footpri

    5/12/26 5:01:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    View All

    3M Announces New Board Appointment

    Jennifer Rumsey, Chair and Chief Executive Officer of Cummins Inc., elected to the Board of DirectorsBrings deep experience leading a global industrial technology companyST. PAUL, Minn., June 8, 2026 /PRNewswire/ -- 3M (NYSE:MMM) announced today the election of Jennifer W. Rumsey to 3M's Board of Directors, effective June 5, 2026. Ms. Rumsey also has been appointed as a member of the Science, Technology and Sustainability Committee of the Board."Jennifer is a highly regarded leader with deep experience driving growth across global industrial markets through innovation and technology," said William M. Brown, 3M's Chairman and Chief Executive Officer. "She will bring valuable perspective to ou

    6/8/26 11:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Annual Meeting Results

    ST. PAUL, Minn., May 12, 2026 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company.Preliminary Shareholder Voting Results3M shareholders today voted on the following business items:1) Shareholders supported 10 directors for one-year terms:David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford Motor CompanyWilliam M. "Bill" Brown, Chairman of the Board and Chief Executive Officer, 3M CompanyAudrey Choi, retired Chief Sustainability Officer and Management Com

    5/12/26 4:46:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M appoints Meagan Linn as Senior Vice President, Government Affairs

    ST. PAUL, Minn., Feb. 16, 2026 /PRNewswire/ -- 3M today announced the appointment of Meagan Linn as Senior Vice President, Government Affairs. In this role, Linn will oversee the company's engagement with the executive branch, policymakers, regulatory agencies, and industry associations, globally to advance public policy dialogue. She will also be responsible for developing business growth through government contracts. Linn brings 20 years of experience in public policy, with 12 years at Northrop Grumman Corporation, most recently as government policy lead and Chief of Staff, an

    2/16/26 10:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/23 10:54:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/22 3:15:56 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care